TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.800
+0.250 (5.49%)
At close: Feb 11, 2026, 4:00 PM EST
4.710
-0.090 (-1.87%)
After-hours: Feb 11, 2026, 7:54 PM EST
TriSalus Life Sciences Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$12.00
Upside
+150.00%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 → $12 | Strong Buy | Maintains | $11 → $12 | +150.00% | Dec 17, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +129.17% | Mar 28, 2025 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +129.17% | Jan 24, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $10 | Buy | Initiates | $10 | +108.33% | Dec 17, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +129.17% | Nov 15, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +129.17% | Nov 11, 2024 |
| Northland Capital Markets | Northland Capital Markets | Buy Initiates $13 | Buy | Initiates | $13 | +160.42% | Oct 25, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $10 | Buy | Initiates | $10 | +108.33% | Sep 16, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +150.00% | Jun 27, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +150.00% | May 30, 2024 |
| JonesTrading | JonesTrading | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +233.33% | May 10, 2024 |